VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
-1.04%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$165M
AUM Growth
-$4.08M
(-2.4%)
Cap. Flow
+$1.01M
Cap. Flow
% of AUM
0.61%
Top 10 Holdings %
Top 10 Hldgs %
6.09%
Holding
488
New
53
Increased
73
Reduced
307
Closed
54
Top Buys
| 1 |
Halliburton
HAL
|
$819K |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$814K |
| 3 |
Steel Dynamics
STLD
|
$798K |
| 4 |
Caterpillar
CAT
|
$792K |
| 5 |
Booking.com
BKNG
|
$789K |
Top Sells
| 1 |
Netflix
NFLX
|
$1.05M |
| 2 |
Vulcan Materials
VMC
|
$1.01M |
| 3 |
CoStar Group
CSGP
|
$998K |
| 4 |
Eli Lilly
LLY
|
$967K |
| 5 |
Ingersoll Rand
IR
|
$913K |
Sector Composition
| 1 | Healthcare | 18.63% |
| 2 | Financials | 17.26% |
| 3 | Technology | 14.89% |
| 4 | Energy | 9.42% |
| 5 | Consumer Discretionary | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Moderna
MRNA
$9.78B
| $249K | 0.15% |
2,414
-5,795
| -71% | -$599K |
|
|
ITCI
227
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $246K | 0.15% |
4,723
-613
| -11% | -$31.9K |
|
228
Aurinia Pharmaceuticals
AUPH
$1.63B
| $240K | 0.15% |
30,857
-3,993
| -11% | -$31K |
|
|
BLUE
229
DELISTED
bluebird bio
BLUE
| $240K | 0.15% |
3,941
-510
| -11% | -$31K |
|
230
Ligand Pharmaceuticals
LGND
$3.25B
| $234K | 0.14% |
3,904
-501
| -11% | -$30K |
|
231
Cheniere Energy
CQP
$26.1B
| $234K | 0.14% |
4,313
-636
| -13% | -$34.5K |
|
232
Digital Realty Trust
DLR
$55.7B
| $228K | 0.14% |
1,882
-439
| -19% | -$53.1K |
|
|
PXD
233
DELISTED
Pioneer Natural Resource Co.
PXD
| $227K | 0.14% |
991
-157
| -14% | -$36K |
|
234
Amylyx Pharmaceuticals
AMLX
$910M
| $224K | 0.14% |
12,223
-1,583
| -11% | -$29K |
|
235
Viper Energy
VNOM
$6.29B
| $219K | 0.13% |
7,871
-183
| -2% | -$5.1K |
|
236
Tronox
TROX
$710M
| $219K | 0.13% |
16,318
-194
| -1% | -$2.61K |
|
237
NRG Energy
NRG
$28.6B
| $219K | 0.13% |
5,687
-1,304
| -19% | -$50.2K |
|
238
Copel
ELP
$6.77B
| $219K | 0.13% |
31,145
-13,953
| -31% | -$97.9K |
|
239
Ultragenyx Pharmaceutical
RARE
$3.07B
| $216K | 0.13% |
6,072
-788
| -11% | -$28.1K |
|
240
KT
KT
$9.78B
| $214K | 0.13% |
16,701
-1,943
| -10% | -$24.9K |
|
241
Kimbell Royalty Partners
KRP
$1.25B
| $213K | 0.13% |
13,337
-2,008
| -13% | -$32.1K |
|
242
CareTrust REIT
CTRE
$7.56B
| $211K | 0.13% |
10,305
-1,780
| -15% | -$36.5K |
|
243
MoonLake Immunotherapeutics
MLTX
$3.77B
| $210K | 0.13% |
3,687
-366
| -9% | -$20.9K |
|
244
Vanda Pharmaceuticals
VNDA
$272M
| $210K | 0.13% |
48,530
-6,275
| -11% | -$27.1K |
|
|
AAT
245
American Assets Trust
AAT
$1.28B
| $209K | 0.13% |
10,764
-2,392
| -18% | -$46.5K |
|
246
Innovative Industrial Properties
IIPR
$1.61B
| $206K | 0.13% |
2,729
-194
| -7% | -$14.7K |
|
247
Vodafone
VOD
$28.5B
| $205K | 0.12% |
21,632
+1,993
| +10% | +$18.9K |
|
248
GeoPark
GPRK
$326M
| $204K | 0.12% |
19,858
-830
| -4% | -$8.53K |
|
249
CVR Partners
UAN
$930M
| $203K | 0.12% |
2,455
-36
| -1% | -$2.97K |
|
250
Petrobras
PBR
$78.7B
| $203K | 0.12% |
13,527
-8,987
| -40% | -$135K |
|